from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1677/dsbF

LFCtreatmentdescriptionclass of inhibitor

-1.260

Amikacinug/mL Amikacintranslation

-1.308

Cap5-10ug/mL Capreomycintranslation

-2.397

Rox10-50 ug/mL Roxithromycintranslation

0.120

SM2-5 ug/mL Streptomycintranslation

-2.096

Tet5-10 ug/mL Tetracyclinetranslation

0.375

Rif0.2-5ug/mL Rifampicintranscription

-0.435

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.130

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.636

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.917

CPZ10-50 ug/mL Chlorpromazinerespiration

0.566

Clofazimine10-13 ug/mL Clofaziminerespiration

0.928

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.894

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.027

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.439

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.740

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.383

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

1.071

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.313

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.324

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.672

KCN5-20 ug/mL Potassium cyaniderespiration

1.396

NaN30.2-2 mM Sodium aziderespiration

0.511

Nigericin50 uM Nigericinrespiration

-1.204

TRC10-150 ug/mL Triclosanrespiration

-0.589

TRZ10-25 ug/mL Thioridazinerespiration

-1.618

Valinomycin0.5-10 uM Valinomycinrespiration

1.259

ZnSO42 mM ZnSO4respiration

0.241

menadione6-10 ug/mL Menadionerespiration

-0.347

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.449

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.416

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.236

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.115

NRP_1Non-replicating persistence stage 1dosRassociated

0.547

Amp0.2mg/mL AmpicillincellWall

0.563

Cephalexin20-100 ug/mL CephalexincellWall

0.294

Cerulenin0.32-5 ug/mL CerulenincellWall

0.395

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.314

EMB10-20 ug/mL EthambutolcellWall

0.851

Eta12-40 ug/mL EthionamidecellWall

1.213

INH0.2-0.4 ug/mL IsoniazidcellWall

0.266

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.303

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.671

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.318

BZA0.12 mg/mL BenzamidearomaticAmides

-0.615

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.838

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.551

H2O24 mM hydrogen peroxideDNAdamaging

-0.647

Levo10 ug/mL LevofloxacinDNAdamaging

0.497

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.159

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.231

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.127

UVUV-irradiationDNAdamaging

-1.042

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.021

Antimycin12.5-50 ug/mL Antimycin A?

0.179

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.898

PA_110-50 ug/mL Antitubercular compound PA-1?

1.024

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.242

PA8240.2-2 ug/mL PA-824?

0.147

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.307

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.392

Verapamil50 uM Verapamil?

0.623

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.166

methoxatin10-20 ug/mL Methoxatin?